Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Dec 2, 2022--
The "Hepatitis B Vaccines: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Hepatitis B Vaccines Market to Reach $3.4 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Hepatitis B Vaccines estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027. Combination Vaccines, one of the segments analyzed in the report, is projected to record 4.4% CAGR and reach US$2.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mono Vaccines segment is readjusted to a revised 3.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $715.6 Million, While China is Forecast to Grow at 6.5% CAGR
The Hepatitis B Vaccines market in the U.S. is estimated at US$715.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$668.6 Million by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.
Select Competitors (Total 14 Featured) -
What's New for 2022?
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/oixc6p
View source version on businesswire.com:https://www.businesswire.com/news/home/20221202005136/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/02/2022 04:45 AM/DISC: 12/02/2022 04:46 AM
http://www.businesswire.com/news/home/20221202005136/en